Ernst & Young: Drug companies investing more in IT-focused projects

Share this content:
Pharmaceutical companies are dramatically increasing their investments in new and innovative offerings to meet the demands of a patient-empowered, data-driven, outcomes-focused future in healthcare, according to a report Ernst & Young. In the last year alone, pharmaceutical company investment in smart phone apps, educational websites, social media platforms, wireless devices and other programs increased 78%, investigators found.